Safety of Same Day Discharge After Elective Percutaneous Coronary Intervention

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

210 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2015-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study intends to determine if there is any difference in the occurrence of major adverse cardiology events in patients discharged on the same day as their elective cardiac angioplasty or discharged one day after their angioplasty.

Hypothesize that same day discharge is as safe as a day later discharge.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)

NCT01068119

Acute Coronary Syndrome

TERMINATED PHASE4

Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Intervention

NCT01230606

Cardiovascular Disease

COMPLETED

Patient Satisfaction and Safety Outcomes After Enrollment in a Same-Day (SD) Percutaneous Coronary Intervention Program

NCT01276132

To Evaluate Clinical Outcomes, Safety, and Satisfaction of Patients Who Have Participated in a Same Day Outpatient Percutaneous Coronary Artery Intervention

COMPLETED

Fast Discharge After Acute Myocardial Infarction Discharge MI

NCT06744322

Acute Myocardial Infarction (AMI)

RECRUITING NA

Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-risk Primary Percutaneous Coronary Intervention (PCI) Patients

NCT00474214

Myocardial Infarction

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Angioplasty Coronary

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Next day discharge

this group will be discharged as is the standard practice at our facility; i.e. the day after the PCI procedure

Group Type NO_INTERVENTION

No interventions assigned to this group

Same Day Discharge

Patients in this arm will be discharged on the same day as their angioplasty.

Group Type EXPERIMENTAL

Same Day Discharge

Intervention Type OTHER

This group will be discharged home, on the same day after their elective angioplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Same Day Discharge

This group will be discharged home, on the same day after their elective angioplasty

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Low risk lesion (according to the ACC classification)
* Normal Pre Catheterization laboratory investigation
* Procedure performed before 3 pm
* procedure performed with ≤ 6 French guiding Catheter
* EF ≥ 35%
* living at a distance of within 15 kilometers from hospital
* caregiver present at home
* elective procedure

Exclusion Criteria

* Acute PCI
* high risk lesions (according to the ACC classification)
* deranged Pre Catheterization laboratory investigations
* Age \>70
* Severe LV dysfunction, CVA
* procedure to be performed with a guiding catheter \>6F
* Use of IIb/IIIa inhibitor
* Creatinine clearance of \< 50

Minimum Eligible Age

21 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No